MELANOMA BRIDGE

December 2nd - 4th, 2021

FACULTY

Sanjiv S. Agarwala
Professor & Chief, Haematology & Oncology, St Luke’s University Hospital and Temple University, Bethlehem, PA, US

Paolo A. Ascierto
Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Department, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Allison Betof
Assistant Attending Physician, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, US

Christian Blank
Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Corrado Caracò
Director of Melanoma and Skin Tumor Surgery, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Richard D. Carvajal
Director of Experimental Therapeutics and Director of the Melanoma Service, Columbia University Medical Center, New York, NY, US

Reinhard Dummer
Professor of Dermatology, University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland

Marc S. Ernstoff
Branch Chief of ImmunoOncology Branch (IOB), Developmental Therapeutics Program, Division of Cancer Therapy & Diagnosis, NCI, NIH, Bethesda, MD, US; Formerly Section Chief of Hematology/Oncology at Dartmouth College’s Geisel School of Medicine, Hanover, NH, US; and Director of the Melanoma Program at the Cleveland Clinic, Cleveland, OH, US.

Soldano Ferrone
Department of Surgery Massachusetts General Hospital, Harvard Medical School, Boston, MA, US

Silvia C. Formenti
Professor and Chairman, Sandra and Edward Meyer Cancer Center, Department of Radiation Oncology Associate Director for Translational Research, Weill Cornell Medicine, New York, NY, USA

Bernard A. Fox
Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Research Center – Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, US

Thomas F. Gajewski
Oncology and Immunology Professor, Department of Pathology and Department of Medicine (Section of Haematology/Oncology) – University of Chicago (Microbiome Center), Chicago, IL, US

Claus Garbe
University Professor of Dermatology, Division of Dermatologic Oncology Department of Dermatology, Eberhard- Karls University Tuebingen, Germany

Jeffrey E. Gershenwald
Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, TX, US

Jean-Jacques Grob
Professor, Head of Dermatology Department, Hopital de la Timone, Aix-Marseille, Marseille, France

Omid Hamid
Chief of Research/ Immuno-Oncology and Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, Los Angeles, CA, US

Patrick Hwu
Patrick Hwu, MD, President & CEO, Moffitt Cancer Center, Tampa, FL, US

Michelle Krogsaard
Associate Professor, Perlmutter Cancer Center, NYU School of Medicine, New York, NY, US

Nikhil Khushalani
Vice Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, US

Roger Lo
Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, CA, US

Georgina V. Long
Co-Medical Director Melanoma Institute Australia, Professor of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, Australia

Jason J. Luke
Director, Cancer Immunotherapeutics Center, Associate Professor of Medicine, UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, US

Amanda Lund
Associate Professor, Ronald O. Perelman Department of Dermatology, Department of Pathology, New York University Langone, Medical School, New York, NY, US

Gabriele Madonna
Melanoma, Cancer Immunotherapy and Development Therapeutics Department, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Francesco Marincola
Global Head of Research, Kite Pharma, Santa Monica, CA, US

Giuseppe Masucci
M.D., Associate Professor, Department of Oncology-Pathology and KcRN, Karolinska Institutet, Cancer Centrum Karolinska (CCK), Karolinska University Hospital, Stockholm, Sweden

Janice Mehnert
Professor of Medicine, NYU Grossman School of Medicine, Associate Director for Clinical Research, Laura and Isaac Perlmutter Cancer Center at NYU, Director, Melanoma and Cutaneous Medical Oncology, Co-Director, Developmental Therapeutics/Phase 1, New York, NY, US

Olivier Michielin
Analytical Oncology Division Director, Oncology Department UNIL CHUV, Lausanne, Switzerland

Bart Neyns
Head of department, Medical Oncology, Universitair Ziekenhuis Brussel, Brussel, Belgium

Nicola Normanno
Cell Biology and Biotherapy Unit, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Iman Osman
Rudolf L. Baer MD Professor of Dermatology, Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, New York University Langone, Medical School, New York, NY, US

Giuseppe Palmieri
President Italian Melanoma Intergroup (IMI), Head of Unit of Cancer Genetics, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy

Solange Peters
Full professor UNIL, Chair Medical Oncology Department, Head of the Specialized Thoracic Tumor Consultation, Oncology Department UNIL CHUV, Lausanne University, Physician in charge of Thoracic Tumor Center, Lausanne, Switzerland – ESMO President, Scientific Coordinator, European Thoracic Oncology Platform (ETOP), JTO Deputy Editor

Poulikos Poulikakos
Associate Professor, Department of Oncological Sciences, Department of Dermatology, The Tisch Cancer Institute, Icahn School of Medicine Mount Sinai, New York, NY, US

Igor Puzanov
Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, US

Sergio Quezada
Professor of Cancer Immunology and Immunotherapy, Immune Regulation & Tumour Immunotherapy Lab, CRUK Senior Cancer Research Fellow, UCL Cancer Institute, University College London, London, UK

Bradley I. Reinfeld
Medical Scientist Training Program, Department of Medicine, Vanderbilt University Medical Center (VUMC), Graduate Program in Cancer Biology, Vanderbilt University, Nashville, TN, US

Caroline Robert
M.D., Ph.D., Head of Dermatology Unit, Institut Gustave Roussy; Co-Director of Melanoma Research Unit, INSERM 981 Paris-Sud University, Paris, France

Piotr Rutkowski

Maria Sklodowska-Curie National Research Institute of Oncology; Head of Department of Soft Tissue/Bone Sarcoma and Melanoma; Deputy Director for National Oncological Strategy and Clinical Trials, Warsaw, Poland

Hussein A. Tawbi
Deputy Chair, Department of Melanoma Medical Oncology, Director of Melanoma Clinical Research & Early Drug Development, Co-Director, MD Anderson Brain Metastasis Clinic, Melanoma Medical Oncology, Investigational Cancer Therapeutics, UT MD Anderson Cancer Center, Houston, TX, US

Alessandro Testori
Dermatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Michele Teng
Associate Professor, Head of the Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USS

Jeffrey S. Weber
Deputy Director, Professor of Oncology, Department of Medicine, Perlmutter Cancer Center, New York University Langone, Medical School, New York, NY, US

Tara Withington
Executive Director, Society of Immunotherapy for Cancer (SITC), Milwaukee, WI, US

Laurence Zitvogel
Group Leader of Tumour immunology and immunotherapy of cancer, European Academy of Tumor Immunology, Institut Gustave Roussy, Villejuif, France